The enterobacterial genotoxins: Cytolethal distending toxin and colibactin

EcoSal Plus

Volumn 7, Issue 1, 2016, Pages 1-21

  Taieb, Frederic ^a   Petit, Claude ^a   Nougayrède, Jean Philippe ^a   Oswald, Eric ^a  

^a UMR 1220 TCEM (INRA ENITAB)   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; COLIBACTIN; CYTOLETHAL DISTENDING TOXIN; MUTAGENIC AGENT; PEPTIDE; POLYKETIDE;

ANIMAL; CELL CYCLE; DNA DAMAGE; ESCHERICHIA COLI; GASTROINTESTINAL TRACT; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY; MOUSE; NEOPLASM; PATHOGENICITY; SALMONELLA ENTERICA SEROVAR TYPHI;

ANIMALS; BACTERIAL TOXINS; CELL CYCLE; DNA DAMAGE; ESCHERICHIA COLI; GASTROINTESTINAL TRACT; HUMANS; MICE; MUTAGENS; NEOPLASMS; PEPTIDES; POLYKETIDES; SALMONELLA TYPHI;

EID: 84996551911     PISSN: None     EISSN: 23246200     Source Type: Journal    
DOI: 10.1128/ecosalplus.ESP-0008-2016     Document Type: Article

References (161)

1. Rosadi F, Fiorentini C, Fabbri A. 2016. Bacterial protein toxins in human cancers. Pathog Dis 74:ftv105. doi:10.1093/femspd/ftv105
2. Irrazábal T, Belcheva A, Girardin SE, Martin A, Philpott DJ. 2014. The multifaceted role of the intestinal microbiota in colon cancer. Mol Cell 54:309-320
3. Popoff MR. 2014. Bacterial factors exploit eukaryotic Rho GTPase signaling cascades to promote invasion and proliferation within their host. Small GTPases 5:5. doi:10.4161/sgtp.28209
4. Rajamuthiah R, Mylonakis E. 2014. Effector triggered immunity. Virulence 5:697-702
5. Nougayrède JP, Taieb F, De Rycke J, Oswald E. 2005. Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol 13:103-110
6. Oswald E, Nougayrède JP, Taieb F, Sugai M. 2005. Bacterial toxins that modulate host cell-cycle progression. Curr Opin Microbiol 8:83-91
7. Cannan WJ, Pederson DS. 2016. Mechanisms and consequences of double-strand DNA break formation in chromatin. J Cell Physiol 231:3-14
8. Zhou BB, Elledge SJ. 2000. The DNA damage response: putting checkpoints in perspective. Nature 408:433-439
9. Ceccaldi R, Rondinelli B, D'Andrea AD. 2016. Repair pathway choices and consequences at the double-strand break. Trends Cell Biol 26:52-64
10. Johnson WM, Lior H. 1988. A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microb Pathog 4:115-126
11. Johnson WM, Lior H. 1988. A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material. Microb Pathog 4:103-113
12. Shenker BJ, Hoffmaster RH, Zekavat A, Yamaguchi N, Lally ET, Demuth DR. 2001. Induction of apoptosis in human T cells by Actinobacillus actinomycetemcomitans cytolethal distending toxin is a consequence of G2 arrest of the cell cycle. J Immunol 167:435-441
13. Shenker BJ, Hoffmaster RH, McKay TL, Demuth DR. 2000. Expression of the cytolethal distending toxin (Cdt) operon in Actinobacillus actinomycetemcomitans: evidence that the CdtB protein is responsible for G2 arrest of the cell cycle in human T cells. J Immunol 165:2612-2618
14. Cortes-Bratti X, Karlsson C, Lagergård T, Thelestam M, Frisan T. 2001. The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways. J Biol Chem 276:5296-5302
15. Ohara M, Oswald E, Sugai M. 2004. Cytolethal distending toxin: a bacterial bullet targeted to nucleus. J Biochem 136:409-413
16. Gelfanova V, Hansen EJ, Spinola SM. 1999. Cytolethal distending toxin of Haemophilus ducreyi induces apoptotic death of Jurkat T cells. Infect Immun 67:6394-6402
17. De Rycke J, Sert V, Comayras C, Tasca C. 2000. Sequence of lethal events in HeLa cells exposed to the G2 blocking cytolethal distending toxin. Eur J Cell Biol 79:192-201
18. Pickett CL, Pesci EC, Cottle DL, Russell G, Erdem AN, Zeytin H. 1996. Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene. Infect Immun 64:2070-2078
19. Sugai M, Kawamoto T, Pérès SY, Ueno Y, Komatsuzawa H, Fujiwara T, Kurihara H, Suginaka H, Oswald E. 1998. The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect Immun 66:5008-5019
20. Cope LD, Lumbley S, Latimer JL, Klesney-Tait J, Stevens MK, Johnson LS, Purven M, Munson RS Jr, Lagergard T, Radolf JD, Hansen EJ. 1997. A diffusible cytotoxin of Haemophilus ducreyi. Proc Natl Acad Sci USA 94:4056-4061
21. Chien CC, Taylor NS, Ge Z, Schauer DB, Young VB, Fox JG. 2000. Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. J Med Microbiol 49:525-534
22. Shima A, Hinenoya A, Asakura M, Sugimoto N, Tsukamoto T, Ito H, Nagita A, Faruque SM, Yamasaki S. 2012. Molecular characterizations of cytolethal distending toxin produced by Providencia alcalifaciens strains isolated from patients with diarrhea. Infect Immun 80:1323-1332
23. Pérès SY, Marchès O, Daigle F, Nougayrède JP, Herault F, Tasca C, De Rycke J, Oswald E. 1997. A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol Microbiol 24:1095-1107
24. Okuda J, Kurazono H, Takeda Y. 1995. Distribution of the cytolethal distending toxin A gene (cdtA) among species of Shigella and Vibrio, and cloning and sequencing of the cdt gene from Shigella dysenteriae. Microb Pathog 18:167-172
25. Hyma KE, Lacher DW, Nelson AM, Bumbaugh AC, Janda JM, Strockbine NA, Young VB, Whittam TS. 2005. Evolutionary genetics of a new pathogenic Escherichia species: Escherichia albertii and related Shigella boydii strains. J Bacteriol 187:619-628
26. Haghjoo E, Galán JE. 2004. Salmonella Typhi encodes a functional cytolethal distending toxin that is delivered into host cells by a bacterialinternalization pathway. Proc Natl Acad Sci USA 101:4614-4619
27. den Bakker HC, Moreno Switt AI, Govoni G, Cummings CA, Ranieri ML, Degoricija L, Hoelzer K, Rodriguez-Rivera LD, Brown S, Bolchacova E, Furtado MR, Wiedmann M. 2011. Genome sequencing reveals diversification of virulence factor content and possible host adaptation in distinct subpopulations of Salmonella enterica. BMC Genomics 12:425. doi:10.1186/1471-2164-12-425
28. Pickett CL, Cottle DL, Pesci EC, Bikah G. 1994. Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Infect Immun 62:1046-1051
29. Scott DA, Kaper JB. 1994. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect Immun 62:244-251
30. Meier C, Oelschlaeger TA, Merkert H, Korhonen TK, Hacker J. 1996. Ability of Escherichia coli isolates that cause meningitis in newborns to invade epithelial and endothelial cells. Infect Immun 64:2391-2399
31. Berlanda Scorza F, Doro F, Rodríguez-Ortega MJ, Stella M, Liberatori S, Taddei AR, Serino L, Gomes Moriel D, Nesta B, Fontana MR, Spagnuolo A, Pizza M, Norais N, Grandi G. 2008. Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic Escherichia coli DeltatolR IHE3034 mutant. Mol Cell Proteomics 7:473-485
32. Tóth I, Hérault F, Beutin L, Oswald E. 2003. Production of cytolethal distending toxins by pathogenic Escherichia coli strains isolated from human and animal sources: establishment of the existence of a new cdt variant (Type IV). J Clin Microbiol 41:4285-4291
33. Tóth I, Nougayrède JP, Dobrindt U, Ledger TN, Boury M, Morabito S, Fujiwara T, Sugai M, Hacker J, Oswald E. 2009. Cytolethal distending toxin type I and type IV genes are framed with lambdoid prophage genes in extraintestinal pathogenic Escherichia coli. Infect Immun 77:492-500
34. Taieb F, Sváb D, Watrin C, Oswald E, Tóth I. 2015. Cytolethal distending toxin A, B and C subunit proteins are necessary for the genotoxic effect of Escherichia coli CDT-V. Acta Vet Hung 63:1-10
35. Tóth I, Schmidt H, Kardos G, Lancz Z, Creuzburg K, Damjanova I, Pászti J, Beutin L, Nagy B. 2009. Virulence genes and molecular typing of different groups of Escherichia coli O157 strains in cattle. Appl Environ Microbiol 75:6282-6291
36. Hinenoya A, Shima K, Asakura M, Nishimura K, Tsukamoto T, Ooka T, Hayashi T, Ramamurthy T, Faruque SM, Yamasaki S. 2014. Molecular characterization of cytolethal distending toxin genepositive Escherichia coli from healthy cattle and swine in Nara, Japan. BMC Microbiol 14:97. doi:10.1186/1471-2180-14-97
37. Asakura M, Hinenoya A, Alam MS, Shima K, Zahid SH, Shi L, Sugimoto N, Ghosh AN, Ramamurthy T, Faruque SM, Nair GB, Yamasaki S. 2007. An inducible lambdoid prophage encoding cytolethal distending toxin (Cdt-I) and a type III effector protein in enteropathogenic Escherichia coli. Proc Natl Acad Sci USA 104:14483-14488
38. Johnson TJ, Kariyawasam S, Wannemuehler Y, Mangiamele P, Johnson SJ, Doetkott C, Skyberg JA, Lynne AM, Johnson JR, Nolan LK. 2007. The genome sequence of avian pathogenic Escherichia coli strain O1:K1:H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes. J Bacteriol 189:3228-3236
39. Janka A, Bielaszewska M, Dobrindt U, Greune L, Schmidt MA, Karch H. 2003. Cytolethal distending toxin gene cluster in enterohemorrhagic Escherichia coli O157:H-and O157:H7: characterization and evolutionary considerations. Infect Immun 71:3634-3638
40. Sváb D, Horváth B, Maróti G, Dobrindt U, Tóth I. 2013. Sequence variability of P2-like prophage genomes carrying the cytolethal distending toxin V operon in Escherichia coli O157. Appl Environ Microbiol 79:4958-4964
41. Allué-Guardia A, Imamovic L, Muniesa M. 2013. Evolution of a self-inducible cytolethal distending toxin type V-encoding bacteriophage from Escherichia coli O157:H7 to Shigella sonnei. J Virol 87:13665-13675
42. Allué-Guardia A, Jofre J, Muniesa M. 2012. Stability and infectivity of cytolethal distending toxin type V gene-carrying bacteriophages in a water mesocosm and under different inactivation conditions. Appl Environ Microbiol 78:5818-5823
43. Orth D, Grif K, Dierich MP, Würzner R. 2006. Cytolethal distending toxins in Shiga toxin-producing Escherichia coli: alleles, serotype distribution and biological effects. J Med Microbiol 55:1487-1492
44. Mainil JG, Jacquemin E, Oswald E. 2003. Prevalence and identity of cdt-related sequences in necrotoxigenic Escherichia coli. Vet Microbiol 94:159-165
45. Oloomi M, Bouzari S. 2008. Molecular profile and genetic diversity of cytolethal distending toxin (CDT)-producing Escherichia coli isolates from diarrheal patients. APMIS 116:125-132
46. Oloomi M, Javadi M, Bouzari S. 2015. Presence of pathogenicity island related and plasmid encoded virulence genes in cytolethal distending toxin producing Escherichia coli isolates from diarrheal cases. Int J Appl Basic Med Res 5:181-186
47. Moriel DG, Bertoldi I, Spagnuolo A, Marchi S, Rosini R, Nesta B, Pastorello I, Corea VA, Torricelli G, Cartocci E, Savino S, Scarselli M, Dobrindt U, Hacker J, Tettelin H, Tallon LJ, Sullivan S, Wieler LH, Ewers C, Pickard D, Dougan G, Fontana MR, Rappuoli R, Pizza M, Serino L. 2010. Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli. Proc Natl Acad Sci USA 107:9072-9077
48. Georgiades K, Raoult D. 2011. Genomes of the most dangerous epidemic bacteria have a virulence repertoire characterized by fewer genes but more toxin-antitoxin modules. PLoS One 6:e17962. doi:10.1371/journal.pone.0017962
49. Ueno Y, Ohara M, Kawamoto T, Fujiwara T, Komatsuzawa H, Oswald E, Sugai M. 2006. Biogenesis of the Actinobacillus actinomycetemcomitans cytolethal distending toxin holotoxin. Infect Immun 74:3480-3487
50. Gargi A, Reno M, Blanke SR. 2012. Bacterial toxin modulation of the eukaryotic cell cycle: are all cytolethal distending toxins created equally? Front Cell InfectMicrobiol 2:124. doi:10.3389/fcimb.2012.00124
51. Nesic D, Hsu Y, Stebbins CE. 2004. Assembly and function of a bacterial genotoxin. Nature 429:429-433
52. Hu X, Nesic D, Stebbins CE. 2006. Comparative structurefunction analysis of cytolethal distending toxins. Proteins 62:421-434
53. McSweeney LA, Dreyfus LA. 2005. Carbohydrate-binding specificity of the Escherichia coli cytolethal distending toxin CdtA-II and CdtC-II subunits. Infect Immun 73:2051-2060
54. Nesic D, Stebbins CE. 2005. Mechanisms of assembly and cellular interactions for the bacterial genotoxin CDT. PLoS Pathog 1:e28. doi:10.1371/annotation/d5831b82-910f-4acc-82e3-ee0e006fd6bf
55. Damek-Poprawa M, Jang JY, Volgina A, Korostoff J, DiRienzo JM. 2012. Localization of Aggregatibacter actinomycetemcomitans cytolethal distending toxin subunits during intoxication of live cells. Infect Immun 80:2761-2770
56. Boesze-Battaglia K, Walker LP, Zekavat A, Dlakic M, Scuron MD, Nygren P, Shenker BJ. 2015. The Aggregatibacter actinomycetemcomitans cytolethal distending toxin active subunit CdtB contains a cholesterol recognition sequence required for toxin binding and subunit internalization. Infect Immun 83:4042-4055
57. Eshraghi A, Maldonado-Arocho FJ, Gargi A, Cardwell MM, Prouty MG, Blanke SR, Bradley KA. 2010. Cytolethal distending toxin family members are differentially affected by alterations in host glycans and membrane cholesterol. J Biol Chem 285:18199-18207
58. Guerra L, Teter K, Lilley BN, Stenerlöw B, Holmes RK, Ploegh HL, Sandvig K, Thelestam M, Frisan T. 2005. Cellular internalization of cytolethal distending toxin: a new end to a known pathway. Cell Microbiol 7:921-934
59. Lai CH, Lai CK, Lin YJ, Hung CL, Chu CH, Feng CL, Chang CS, Su HL. 2013. Characterization of putative cholesterol recognition/interaction amino acid consensus-like motif of Campylobacter jejuni cytolethal distending toxin C. PLoS One 8:e66202. doi:10.1371/journal .pone.0066202
60. Lai CK, Su JC, Lin YH, Chang CS, Feng CL, Lin HJ, Lin CJ, Tseng GC, Liu HH, Hsieh JT, Su HL, Lai CH. 2015. Involvement of cholesterol in Campylobacter jejuni cytolethal distending toxininduced pathogenesis. Future Microbiol 10:489-501
61. Lara-Tejero M, Galán JE. 2001. CdtA, CdtB, and CdtC form a tripartite complex that is required for cytolethal distending toxin activity. Infect Immun 69:4358-4365
62. Frisk A, Lebens M, Johansson C, Ahmed H, Svensson L, Ahlman K, Lagergård T. 2001. The role of different protein components from the Haemophilus ducreyi cytolethal distending toxin in the generation of cell toxicity. Microb Pathog 30:313-324
63. Shenker BJ, Besack D, McKay T, Pankoski L, Zekavat A, Demuth DR. 2004. Actinobacillus actinomycetemcomitans cytolethal distending toxin (Cdt): evidence that the holotoxin is composed of three subunits: CdtA, CdtB, and CdtC. J Immunol 172:410-417
64. Mao X, DiRienzo JM. 2002. Functional studies of the recombinant subunits of a cytolethal distending holotoxin. Cell Microbiol 4:245-255
65. Deng K, Latimer JL, Lewis DA, Hansen EJ. 2001. Investigation of the interaction among the components of the cytolethal distending toxin of Haemophilus ducreyi. Biochem Biophys Res Commun 285:609-615
66. Lewis DA, Stevens MK, Latimer JL, Ward CK, Deng K, Blick R, Lumbley SR, Ison CA, Hansen EJ. 2001. Characterization of Haemophilus ducreyi cdtA, cdtB, and cdtC mutants in in vitro and in vivo systems. Infect Immun 69:5626-5634
67. Akifusa S, Heywood W, Nair SP, Stenbeck G, Henderson B. 2005. Mechanism of internalization of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Microbiology 151:1395-1402
68. Akifusa S, Poole S, Lewthwaite J, Henderson B, Nair SP. 2001. Recombinant Actinobacillus actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis. Infect Immun 69:5925-5930
69. Dixon SD, Huynh MM, Tamilselvam B, Spiegelman LM, Son SB, Eshraghi A, Blanke SR, Bradley KA. 2015. Distinct roles for CdtA and CdtC during intoxication by Cytolethal Distending Toxins. PLoS One 10:e0143977. doi:10.1371/journal.pone.0143977
70. Hu X, Stebbins CE. 2006. Dynamics and assembly of the cytolethal distending toxin. Proteins 65:843-855
71. Murase K, Martin P, Porcheron G, Houle S, Helloin E, Pénary M, Nougayrède JP, Dozois CM, Hayashi T, Oswald E. 2016. HlyF produced by extraintestinal pathogenic Escherichia coli is a virulence factor that regulates outer membrane vesicle biogenesis. J Infect Dis 213:856-865
72. Lindmark B, Rompikuntal PK, Vaitkevicius K, Song T, Mizunoe Y, Uhlin BE, Guerry P, Wai SN. 2009. Outer membrane vesiclemediated release of cytolethal distending toxin (CDT) from Campylobacter jejuni. BMC Microbiol 9:220. doi:10.1186/1471-2180-9-220
73. Rompikuntal PK, Thay B, Khan MK, Alanko J, Penttinen AM, Asikainen S, Wai SN, Oscarsson J. 2012. Perinuclear localization of internalized outer membrane vesicles carrying active cytolethal distending toxin from Aggregatibacter actinomycetemcomitans. Infect Immun 80:31-42
74. Kuehn MJ, Kesty NC. 2005. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev 19:2645-2655
75. Carette JE, Guimaraes CP, Wuethrich I, Blomen VA, Varadarajan M, Sun C, Bell G, Yuan B, Muellner MK, Nijman SM, Ploegh HL, Brummelkamp TR. 2011. Global gene disruption in human cells to assign genes to phenotypes by deep sequencing. Nat Biotechnol 29:542-546
76. Gargi A, Tamilselvam B, Powers B, Prouty MG, Lincecum T, Eshraghi A, Maldonado-Arocho FJ, Wilson BA, Bradley KA, Blanke SR. 2013. Cellular interactions of the cytolethal distending toxins from Escherichia coli and Haemophilus ducreyi. J Biol Chem 288:7492-7505
77. DiRienzo JM. 2014. Uptake and processing of the cytolethal distending toxin by mammalian cells. Toxins (Basel) 6:3098-3116
78. McSweeney LA, Dreyfus LA. 2004. Nuclear localization of the Escherichia coli cytolethal distending toxin CdtB subunit. Cell Microbiol 6:447-458
79. Nishikubo S, Ohara M, Ueno Y, Ikura M, Kurihara H, Komatsuzawa H, Oswald E, Sugai M. 2003. An N-terminal segment of the active component of the bacterial genotoxin cytolethal distending toxin B (CDTB) directs CDTB into the nucleus. J Biol Chem 278:50671-50681
80. Eshraghi A, Dixon SD, Tamilselvam B, Kim EJ, Gargi A, Kulik JC, Damoiseaux R, Blanke SR, Bradley KA. 2014. Cytolethal distending toxins require components of the ER-associated degradation pathway for host cell entry. PLoS Pathog 10:e1004295
81. Elwell CA, Dreyfus LA. 2000. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol Microbiol 37:952-963
82. Elwell C, Chao K, Patel K, Dreyfus L. 2001. Escherichia coli CdtB mediates cytolethal distending toxin cell cycle arrest. Infect Immun 69:3418-3422
83. Li L, Sharipo A, Chaves-Olarte E, Masucci MG, Levitsky V, Thelestam M, Frisan T. 2002. The Haemophilus ducreyi cytolethal distending toxin activates sensors ofDNAdamage and repair complexes in proliferating and non-proliferating cells. Cell Microbiol 4:87-99
84. Hassane DC, Lee RB, Mendenhall MD, Pickett CL. 2001. Cytolethal distending toxin demonstrates genotoxic activity in a yeast model. Infect Immun 69:5752-5759
85. Fedor Y, Vignard J, Nicolau-Travers ML, Boutet-Robinet E, Watrin C, Salles B, Mirey G. 2013. From single-strand breaks to double-strand breaks during S-phase: a new mode of action of the Escherichia coli Cytolethal Distending Toxin. Cell Microbiol 15:1-15
86. Sert V, Cans C, Tasca C, Bret-Bennis L, Oswald E, Ducommun B, De Rycke J. 1999. The bacterial cytolethal distending toxin (CDT) triggers a G2 cell cycle checkpoint in mammalian cells without preliminary induction of DNA strand breaks. Oncogene 18:6296-6304
87. Taieb F, Nougayrède JP, Watrin C, Samba-Louaka A, Oswald E. 2006. Escherichia coli cyclomodulin Cif induces G2 arrest of the host cell cycle without activation of the DNA-damage checkpoint-signalling pathway. Cell Microbiol 8:1910-1921
88. Fahrer J, Huelsenbeck J, Jaurich H, Dörsam B, Frisan T, Eich M, Roos WP, Kaina B, Fritz G. 2014. Cytolethal distending toxin (CDT) is a radiomimetic agent and induces persistent levels of DNA doublestrand breaks in human fibroblasts. DNA Repair (Amst) 18:31-43
89. Bezine E, Vignard J, Mirey G. 2014. The cytolethal distending toxin effects on Mammalian cells: a DNA damage perspective. Cells 3:592-615
90. Frisan T, Cortes-Bratti X, Chaves-Olarte E, Stenerlöw B, Thelestam M. 2003. The Haemophilus ducreyi cytolethal distending toxin induces DNA double-strand breaks and promotes ATMdependent activation of RhoA. Cell Microbiol 5:695-707
91. Guerra L, Albihn A, Tronnersjö S, Yan Q, Guidi R, Stenerlöw B, Sterzenbach T, Josenhans C, Fox JG, Schauer DB, Thelestam M, Larsson LG, Henriksson M, Frisan T. 2010. Myc is required for activation of the ATM-dependent checkpoints in response to DNA damage. PLoS One 5:e8924. doi:10.1371/journal.pone.0008924
92. Guerra L, Carr HS, Richter-Dahlfors A, Masucci MG, Thelestam M, Frost JA, Frisan T. 2008. A bacterial cytotoxin identifies the RhoA exchange factor Net1 as a key effector in the response to DNA damage. PLoS One 3:e2254. doi:10.1371/journal.pone.0002254
93. Guerra L, Guidi R, Slot I, Callegari S, Sompallae R, Pickett CL, Åström S, Eisele F, Wolf D, Sjögren C, Masucci MG, Frisan T. 2011. Bacterial genotoxin triggers FEN1-dependent RhoA activation, cytoskeleton remodeling and cell survival. J Cell Sci 124:2735-2742
94. Blazkova H, Krejcikova K, Moudry P, Frisan T, Hodny Z, Bartek J. 2010. Bacterial intoxication evokes cellular senescence with persistent DNA damage and cytokine signalling. J Cell Mol Med 14:357-367
95. Guidi R, Guerra L, Levi L, Stenerlöw B, Fox JG, Josenhans C, Masucci MG, Frisan T. 2013. Chronic exposure to the cytolethal distending toxins of Gram-negative bacteria promotes genomic instability and altered DNA damage response. Cell Microbiol 15:98-113
96. Shenker BJ, Walker LP, Zekavat A, Dlakic M, Boesze-Battaglia K. 2014. Blockade of the PI-3K signalling pathway by the Aggregatibacter actinomycetemcomitans cytolethal distending toxin induces macrophages to synthesize and secrete pro-inflammatory cytokines. Cell Microbiol 16:1391-1404
97. Shenker BJ, Dlakic M, Walker LP, Besack D, Jaffe E, LaBelle E, Boesze-Battaglia K. 2007. A novel mode of action for a microbialderived immunotoxin: the cytolethal distending toxin subunit B exhibits phosphatidylinositol 3,4,5-triphosphate phosphatase activity. J Immunol 178:5099-5108
98. Shenker BJ, Boesze-Battaglia K, Scuron MD,Walker LP, Zekavat A, Dlakic M. 2016.The toxicity of the Aggregatibacter actinomycetemcomitans cytolethal distending toxin correlates with its phosphatidylinositol-3,4,5-triphosphate phosphatase activity. Cell Microbiol 18:223-243
99. Suez J, Porwollik S, Dagan A, Marzel A, Schorr YI, Desai PT, Agmon V, McClelland M, Rahav G, Gal-Mor O. 2013. Virulence gene profiling and pathogenicity characterization of non-typhoidal Salmonella accounted for invasive disease in humans. PLoS One 8: e58449. doi:10.1371/journal.pone.0058449
100. Spanò S, Ugalde JE, Galán JE. 2008. Delivery of a Salmonella Typhi exotoxin from a host intracellular compartment. Cell Host Microbe 3:30-38
101. Mezal EH, Bae D, Khan AA. 2014. Detection and functionality of the CdtB, PltA, and PltB from Salmonella enterica serovar Javiana. Pathog Dis 72:95-103
102. Rodriguez-Rivera LD, Bowen BM, den Bakker HC, Duhamel GE, Wiedmann M. 2015. Characterization of the cytolethal distending toxin (typhoid toxin) in non-typhoidal Salmonella serovars. Gut Pathog 7:19. doi:10.1186/s13099-015-0065-1
103. Song J, Gao X, Galán JE. 2013. Structure and function of the Salmonella Typhi chimaeric A(2)B(5) typhoid toxin. Nature 499:350-354
104. Spanò S, Galán JE. 2008. A novel pathway for exotoxin delivery by an intracellular pathogen. Curr Opin Microbiol 11:15-20
105. Guidi R, Levi L, Rouf SF, Puiac S, Rhen M, Frisan T. 2013. Salmonella enterica delivers its genotoxin through outer membrane vesicles secreted from infected cells. Cell Microbiol 15:2034-2050
106. Ge Z, Feng Y, Whary MT, Nambiar PR, Xu S, Ng V, Taylor NS, Fox JG. 2005. Cytolethal distending toxin is essential for Helicobacter hepaticus colonization in outbred Swiss Webster mice. Infect Immun 73:3559-3567
107. Pratt JS, Sachen KL, Wood HD, Eaton KA, Young VB. 2006. Modulation of host immune responses by the cytolethal distending toxin of Helicobacter hepaticus. Infect Immun 74:4496-4504
108. Ge Z, Rogers AB, Feng Y, Lee A, Xu S, Taylor NS, Fox JG. 2007. Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell Microbiol 9:2070-2080
109. Fox JG, Rogers AB, Whary MT, Ge Z, Taylor NS, Xu S, Horwitz BH, Erdman SE. 2004. Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect Immun 72:1116-1125
110. Nougayrède JP, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, Buchrieser C, Hacker J, Dobrindt U, Oswald E. 2006. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313:848-851
111. Comayras C, Tasca C, Pérès SY, Ducommun B, Oswald E, De Rycke J. 1997. Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing cdc2 protein kinase dephosphorylation and activation. Infect Immun 65:5088-5095
112. Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrède JP. 2010. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci USA 107:11537-11542
113. Secher T, Samba-Louaka A, Oswald E, Nougayrède JP. 2013. Escherichia coli producing colibactin triggers premature and transmissible senescence in mammalian cells. PLoS One 8:e77157. doi:10.1371/journal.pone.0077157
114. Cougnoux A, Dalmasso G, Martinez R, Buc E, Delmas J, Gibold L, Sauvanet P, Darcha C, Déchelotte P, Bonnet M, Pezet D, Wodrich H, Darfeuille-Michaud A, Bonnet R. 2014. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut 63:1932-1942
115. Dalmasso G, Cougnoux A, Delmas J, Darfeuille-Michaud A, Bonnet R. 2014. The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment. Gut Microbes 5:675-680
116. Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, Rhodes JM, Stintzi A, Simpson KW, Hansen JJ, Keku TO, Fodor AA, Jobin C. 2012. Intestinal inflammation targets cancerinducing activity of the microbiota. Science 338:120-123
117. McCarthy AJ, Martin P, Cloup E, Stabler RA, Oswald E, Taylor PW. 2015. The genotoxin colibactin is a determinant of virulence in Escherichia coli K1 experimental neonatal systemic infection. Infect Immun 83:3704-3711
118. Payros D, Secher T, Boury M, Brehin C, Ménard S, Salvador-Cartier C, Cuevas-Ramos G, Watrin C, Marcq I, Nougayrède JP, Dubois D, Bedu A, Garnier F, Clermont O, Denamur E, Plaisancié P, Theodorou V, Fioramonti J, Olier M, Oswald E. 2014. Maternally acquired genotoxic Escherichia coli alters offspring's intestinal homeostasis. Gut Microbes 5:313-325
119. Beld J, Lee DJ, Burkart MD. 2015. Fatty acid biosynthesis revisited: structure elucidation and metabolic engineering. Mol Biosyst 11:38-59
120. Martin P, Marcq I, Magistro G, Penary M, Garcie C, Payros D, Boury M, Olier M, Nougayrède JP, Audebert M, Chalut C, Schubert S, Oswald E. 2013. Interplay between siderophores and colibactin genotoxin biosynthetic pathways in Escherichia coli. PLoS Pathog 9: e1003437. doi:10.1371/journal.ppat.1003437
121. Bian X, Fu J, Plaza A, Herrmann J, Pistorius D, Stewart AF, Zhang Y, Müller R. 2013. In vivo evidence for a prodrug activation mechanism during colibactin maturation. ChemBioChem 14:1194-1197
122. Vizcaino MI, Crawford JM. 2015. The colibactin warhead crosslinks DNA. Nat Chem 7:411-417
123. Brotherton CA, Wilson M, Byrd G, Balskus EP. 2015. Isolation of a metabolite from the pks island provides insights into colibactin biosynthesis and activity. Org Lett 17:1545-1548
124. Brachmann AO, Garcie C, Wu V, Martin P, Ueoka R, Oswald E, Piel J. 2015. Colibactin biosynthesis and biological activity depend on the rare aminomalonyl polyketide precursor. Chem Commun (Camb) 51:13138-13141
125. Zha L, Wilson MR, Brotherton CA, Balskus EP. 2016. Characterization of polyketide synthase machinery from the pks island facilitates isolation of a candidate precolibactin. ACS Chem Biol doi:10.1021/acschembio.6b00014
126. Mousa JJ, Yang Y, Tomkovich S, Shima A, Newsome RC, Tripathi P, Oswald E, Bruner SD, Jobin C. 2016. MATE transport of the E. coli-derived genotoxin colibactin. New Microbiol 1:1-7
127. Dubois D, Baron O, Cougnoux A, Delmas J, Pradel N, Boury M, Bouchon B, Bringer MA, Nougayrède JP, Oswald E, Bonnet R. 2011. ClbP is a prototype of a peptidase subgroup involved in biosynthesis of nonribosomal peptides. J Biol Chem 286:35562-35570
128. Cougnoux A, Gibold L, Robin F, Dubois D, Pradel N, Darfeuille-Michaud A, Dalmasso G, Delmas J, Bonnet R. 2012. Analysis of structure-function relationships in the colibactin-maturating enzyme ClbP. J Mol Biol 424:203-214
129. Brotherton CA, Balskus EP. 2013. A prodrug resistance mechanism is involved in colibactin biosynthesis and cytotoxicity. J Am Chem Soc 135:3359-3362
130. Balskus EP. 2015. Colibactin: understanding an elusive gut bacterial genotoxin. Nat Prod Rep 32:1534-1540
131. Bossuet-Greif N, Dubois D, Petit C, Tronnet S, Martin P, Bonnet R, Oswald E, Nougayrède JP. 2016. Escherichia coli ClbS is a colibactin resistance protein. Mol Microbiol 99:897-908
132. Li ZR, Li Y, Lai JY, Tang J, Wang B, Lu L, Zhu G, Wu X, Xu Y, Qian PY. 2015. Critical intermediates reveal new biosynthetic events in the enigmatic colibactin pathway. ChemBioChem 16:1715-1719
133. Tanasova M, Sturla SJ. 2012. Chemistry and biology of acylfulvenes: sesquiterpene-derived antitumor agents. Chem Rev 112:3578-3610
134. Vizcaino MI, Engel P, Trautman E, Crawford JM. 2014. Comparative metabolomics and structural characterizations illuminate colibactin pathway-dependent small molecules. J Am Chem Soc 136:9244-9247
135. Bode HB. 2015. The microbes inside us and the race for colibactin. Angew Chem Int Ed Engl 54:10408-10411
136. Chaudhuri RR, Henderson IR. 2012. The evolution of the Escherichia coli phylogeny. Infect Genet Evol 12:214-226
137. Dubois D, Delmas J, Cady A, Robin F, Sivignon A, Oswald E, Bonnet R. 2010. Cyclomodulins in urosepsis strains of Escherichia coli. J Clin Microbiol 48:2122-2129
138. Johnson JR, Johnston B, Kuskowski MA, Nougayrede JP, Oswald E. 2008. Molecular epidemiology and phylogenetic distribution of the Escherichia coli pks genomic island. J Clin Microbiol 46:3906-3911
139. Krieger JN, Dobrindt U, Riley DE, Oswald E. 2011. Acute Escherichia coli prostatitis in previously health young men: bacterial virulence factors, antimicrobial resistance, and clinical outcomes. Urology 77:1420-1425
140. Putze J, Hennequin C, Nougayrède JP, Zhang W, Homburg S, Karch H, Bringer MA, Fayolle C, Carniel E, RabschW, Oelschlaeger TA, Oswald E, Forestier C, Hacker J, Dobrindt U. 2009. Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae. Infect Immun 77:4696-4703
141. Lai YC, Lin AC, Chiang MK, Dai YH, Hsu CC, Lu MC, Liau CY, Chen YT. 2014. Genotoxic Klebsiella pneumoniae in Taiwan. PLoS One 9:e96292
142. Marcq I, Martin P, Payros D, Cuevas-Ramos G, Boury M, Watrin C, Nougayrède JP, Olier M, Oswald E. 2014. The genotoxin colibactin exacerbates lymphopenia and decreases survival rate in mice infected with septicemic Escherichia coli. J Infect Dis 210:285-294
143. Schubert S, Picard B, Gouriou S, Heesemann J, Denamur E. 2002. Yersinia high-pathogenicity island contributes to virulence in Escherichia coli causing extraintestinal infections. Infect Immun 70:5335-5337
144. Fanaro S, Chierici R, Guerrini P, Vigi V. 2003. Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 91:48-55
145. Nowrouzian FL, Oswald E. 2012. Escherichia coli strains with the capacity for long-term persistence in the bowel microbiota carry the potentially genotoxic pks island. Microb Pathog 53:180-182
146. Tenaillon O, Skurnik D, Picard B, Denamur E. 2010. The population genetics of commensal Escherichia coli. Nat Rev Microbiol 8:207-217
147. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. 1999. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354:635-639
148. Schultz M. 2008. Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflamm Bowel Dis 14:1012-1018
149. Olier M, Marcq I, Salvador-Cartier C, Secher T, Dobrindt U, Boury M, Bacquié V, Pénary M, Gaultier E, Nougayrède JP, Fioramonti J, Oswald E. 2012. Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity. Gut Microbes 3:501-509
150. Secher T, Payros D, Brehin C, Boury M, Watrin C, Gillet M, Bernard-Cadenat I, Menard S, Theodorou V, Saoudi A, Olier M, Oswald E. 2015. Oral tolerance failure upon neonatal gut colonization with Escherichia coli producing the genotoxin colibactin. Infect Immun 83:2420-2429
151. Loeb LA, Harris CC. 2008. Advances in chemical carcinogenesis: a historical review and prospective. Cancer Res 68:6863-6872
152. Buc E, Dubois D, Sauvanet P, Raisch J, Delmas J, Darfeuille-Michaud A, Pezet D, Bonnet R. 2013. High prevalence of mucosaassociated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS One 8:e56964. doi:10.1371/journal.pone.0056964
153. Raisch J, Buc E, Bonnet M, Sauvanet P, Vazeille E, de Vallée A, Déchelotte P, Darcha C, Pezet D, Bonnet R, Bringer MA, Darfeuille-Michaud A. 2014. Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation. World J Gastroenterol 20:6560-6572
154. Bailey CE, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ. 2015. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg 150:17-22
155. Nipic D, Podlesek Z, Budic M, Crnigoj M, Žgur-Bertok D. 2013. Escherichia coli uropathogenic-specific protein, Usp, is a bacteriocin-like genotoxin. J Infect Dis 208:1545-1552
156. Crnigoj M, Podlesek Z, Budic M, Žgur-Bertok D. 2014. The Escherichia coli uropathogenic-specific-protein-associated immunity protein 3 (Imu3) has nucleic acid-binding activity. BMC Microbiol 14:16
157. Bergounioux J, Elisee R, Prunier AL, Donnadieu F, Sperandio B, Sansonetti P, Arbibe L. 2012. Calpain activation by the Shigella flexneri effector VirA regulates key steps in the formation and life of the bacterium's epithelial niche. Cell Host Microbe 11:240-252
158. Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, Englyst H, Williams HF, Rhodes JM. 2004. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 127:80-93
159. Maddocks OD, Short AJ, Donnenberg MS, Bader S, Harrison DJ. 2009. Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans. PLoS One 4:e5517. doi:10.1371/journal. pone.0005517
160. Maddocks OD, Scanlon KM, Donnenberg MS. 2013. An Escherichia coli effector protein promotes host mutation via depletion of DNA mismatch repair proteins. MBio 4:e00152-e13
161. Roukos V, Misteli T. 2014. The biogenesis of chromosome translocations. Nat Cell Biol 16:293-300